Amgen Inc (AMGN · NASDAQ)

AMGN · MARKET VIEW

Market view · as of Jun 1, 2026

Revenue (TTM)
$37.22B
+5.8% YoY
Gross margin
71.4%
EPS (latest q)
$5.15
vs $4.77 est · beat
52-wk position
53.6%
-14.6% vs 52w high · +0.6% 1mo

Price (last ~year)

Amgen Inc. (AMGN) reported Q1 2026 revenue of $8.62 billion and EPS of $5.15, exceeding analyst estimates of $4.77. The company maintains a $181.77 billion market capitalization with a 33.8% operating margin and $57.32 billion in total debt. Shares currently trade at $329.13, reflecting a 9.8% decline over the last three months and placing the stock at 53.6% of its 52-week range.

Valuation

Market cap
$181.77B
P/E
23.42
PEG
2.226
P/B
19.78
P/S
4.884
EV/EBITDA
13.62
Beta
0.435
Analyst target
$352.23

Quality & returns

Gross margin
71.4%
Operating margin
33.8%
Profit margin
21.0%
ROE
101.3%
ROA
8.3%

Price movement

Last
$329.13
1-month
+0.6%
3-month
-9.8%
RSI (14)
52
vs SMA200
+1.6%
52-wk position
53.6% -14.6% vs high

Quarterly trajectory

Revenue by quarter (oldest → newest)

QuarterRevenueOp incomeNet incomeEBITDA
2026-03-31$8.62B$2.67B$1.82B$2.74B
2025-12-31$9.90B$3.94B$1.33B$5.07B
2025-09-30$9.56B$2.53B$3.22B$5.91B
2025-06-30$9.17B$2.64B$1.43B$3.62B

Recent news

Sources this view read

  • fundamentals Company overview & valuation (Alpha Vantage OVERVIEW)
  • filing Quarterly financial statements (Alpha Vantage INCOME/BALANCE/CASH)
  • earnings Reported earnings history (Alpha Vantage EARNINGS)
  • prices Adjusted daily prices (Alpha Vantage TIME_SERIES_DAILY_ADJUSTED)